Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases

Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases

Cardiovascular disease (CVD) is one of the most severe diseases in clinics. Fibroblast growth factor 21 (FGF21) is regarded as an important metabolic regulator playing a therapeutic role in diabetes and its complications. The heart is a key target as well as a source of FGF21 which is involved in he...

書誌詳細
主要な著者:	Peng Cheng, Fangfang Zhang, Lechu Yu, Xiufei Lin, Luqing He, Xiaokun Li, Xuemian Lu, Xiaoqing Yan, Yi Tan, Chi Zhang
フォーマット:	論文
言語:	English
出版事項:	Hindawi Limited 2016-01-01
シリーズ:	Journal of Diabetes Research
オンライン･アクセス:	http://dx.doi.org/10.1155/2016/1540267

類似資料

Attenuation of hyperlipidemia- and diabetes-induced early-stage apoptosis and late-stage renal dysfunction via administration of fibroblast growth factor-21 is associated with suppression of renal inflammation.
著者:: Chi Zhang, 等
出版事項: (2013-01-01)

Biological and pharmacological functions of the FGF19- and FGF21-coreceptor beta klotho
著者:: Alexandra S. Aaldijk, 等
出版事項: (2023-05-01)

Fibroblast Growth Factor 21 Attenuates Diabetes-Induced Renal Fibrosis by Negatively Regulating TGF-β-p53-Smad2/3-Mediated Epithelial-to-Mesenchymal Transition via Activation of AKT
著者:: Sundong Lin, 等
出版事項: (2020-02-01)

The role of FGF21 in the pathogenesis of cardiovascular disease
著者:: Ying Zhang, 等
出版事項: (2021-12-01)

Therapeutic Effects of Fibroblast Growth Factor-21 on Diabetic Nephropathy and the Possible Mechanism in Type 1 Diabetes Mellitus Mice
著者:: Wenya Weng, 等
出版事項: (2020-08-01)

The Roles and Pharmacological Effects of FGF21 in Preventing Aging-Associated Metabolic Diseases
著者:: Junbin Yan, 等
出版事項: (2021-03-01)

Discrete Aspects of FGF21 In Vivo Pharmacology Do Not Require UCP1
著者:: Ricardo J. Samms, 等
出版事項: (2015-05-01)

Physiology & pharmacology : the cardiovascular system /
著者:: 295599 Mok, Josephine SL, 等
出版事項: (2004)

Differential specificity of endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in complex with KLB.
著者:: Chaofeng Yang, 等
出版事項: (2012-01-01)

Role of FGF21 in mediating the effect of phosphatidylcholine on GBM
著者:: Peng Wang, 等
出版事項: (2024-09-01)

FGF19 and FGF21: In NASH we trust
著者:: Saswata Talukdar, 等
出版事項: (2021-04-01)

Research perspectives on the regulation and physiological functions of FGF21 and its association with NAFLD
著者:: Takeshi eInagaki
出版事項: (2015-09-01)

Association between FGF19, FGF21 and lipocalin-2, and diabetes progression in PCOS
著者:: Feifei Cheng, 等
出版事項: (2021-10-01)

Physiology and pharmacological targeting of phase separation
著者:: Fangfang Wang, 等
出版事項: (2024-01-01)

Lower cerebrospinal fluid/plasma fibroblast growth factor 21 (FGF21) ratios and placental FGF21 production in gestational diabetes.
著者:: Bee K Tan, 等
出版事項: (2013-01-01)

Zinc Supplementation Prevented Type 2 Diabetes-Induced Liver Injury Mediated by the Nrf2-MT Antioxidative Pathway
著者:: Lechu Yu, 等
出版事項: (2021-01-01)

Fundamentals of FGF19 & FGF21 action in vitro and in vivo.
著者:: Andrew C Adams, 等
出版事項: (2012-01-01)

Analysis of Functional Promoter of Camel FGF21 Gene and Identification of Small Compounds Targeting FGF21 Protein
著者:: Fang Yong, 等
出版事項: (2023-07-01)

FGF19 and FGF21 for the Treatment of NASH—Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human
著者:: Emma Henriksson, 等
出版事項: (2020-12-01)

FGF21 and cardiac physiopathology
著者:: Anna ePlanavila, 等
出版事項: (2015-08-01)

A better anti-diabetic recombinant human fibroblast growth factor 21 (rhFGF21) modified with polyethylene glycol.
著者:: Zhifeng Huang, 等
出版事項: (2011-01-01)

FGF21 as an Endocrine Regulator in Lipid Metabolism: From Molecular Evolution to Physiology and Pathophysiology
著者:: Yusuke Murata, 等
出版事項: (2011-01-01)

FGF21 alleviates microvascular damage following limb ischemia/reperfusion injury by TFEB-mediated autophagy enhancement and anti-oxidative response
著者:: Fanfeng Chen, 等
出版事項: (2022-10-01)

FGF21 as a Stress Hormone: The Roles of FGF21 in Stress Adaptation and the Treatment of Metabolic Diseases
著者:: Kook Hwan Kim, 等
出版事項: (2014-08-01)

BCAA mediated microbiota-liver-heart crosstalk regulates diabetic cardiomyopathy via FGF21
著者:: Hong Zheng, 等
出版事項: (2024-08-01)

The Suitability of FGF21 and FGF23 as New Biomarkers in Endometrial Cancer Patients
著者:: Aneta Cymbaluk-Płoska, 等
出版事項: (2020-06-01)

Retraction: Physiology and pharmacology of the cardiovascular adrenergic system.
著者:: Frontiers ePhysiology Editorial Office
出版事項: (2015-11-01)

Pharmacological FGF21 signals to glutamatergic neurons to enhance leptin action and lower body weight during obesity
著者:: Kristin E. Claflin, 等
出版事項: (2022-10-01)

Advances in Biological Functions and Clinical Studies of FGF21
著者:: Lin W, 等
出版事項: (2021-07-01)

FGF21 requires βklotho to act in vivo.
著者:: Andrew C Adams, 等
出版事項: (2012-01-01)

Paradoxical regulation of human FGF21 by both fasting and feeding signals: is FGF21 a nutritional adaptation factor?
著者:: Takashi Uebanso, 等
出版事項: (2011-01-01)

Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity
著者:: Archita Agrawal, 等
出版事項: (2018-07-01)

FGF21 protects against HFpEF by improving cardiac mitochondrial bioenergetics in mice
著者:: Ke Zhang, 等
出版事項: (2025-02-01)

High-level expression and purification of soluble recombinant FGF21 protein by SUMO fusion in <it>Escherichia coli</it>
著者:: Huang Yadong, 等
出版事項: (2010-02-01)

FGF21 Is Associated with Acanthosis Nigricans in Obese Patients
著者:: Yueye Huang, 等
出版事項: (2016-01-01)

Fatty Acid Desaturase 1 Influences Hepatic Lipid Homeostasis by Modulating the PPARα‐FGF21 Axis
著者:: Shaminie Athinarayanan, 等
出版事項: (2021-03-01)

Decreased FGF19 and FGF21: possible underlying common pathogenic mechanism of metabolic and cognitive dysregulation in depression
著者:: Mimi Tang, 等
出版事項: (2023-05-01)

FGF21 as Modulator of Metabolism in Health and Disease
著者:: Caterina Tezze, 等
出版事項: (2019-04-01)

FGF-21 levels in polyuria-polydipsia syndrome
著者:: Julie Refardt, 等
出版事項: (2018-12-01)

CREBH Improves Diet-Induced Obesity, Insulin Resistance, and Metabolic Disturbances by FGF21-Dependent and FGF21-Independent Mechanisms
著者:: Aoi Satoh, 等
出版事項: (2020-03-01)